From Patient Advocates to Pharma, Groups Weigh in on Trump Blueprint for Drug Costs
Giving patients relief at the pharmacy counter is essential, but it won’t be simple, based on responses from advocacy groups and stakeholders who weighed in after HHS asked for comments on President Donald Trump’s blueprint for reining in what consumers pay for prescription drugs.
From Patient Advocates to Pharma, Groups Weigh in on Trump Blueprint for Drug Costs
Giving patients relief at the pharmacy counter is essential, but it won’t be simple, based on responses from advocacy groups and stakeholders who weighed in after HHS asked for comments on President Donald Trump’s blueprint for reining in what consumers pay for prescription drugs.
